1
by Ho, Chuong, Lau, Andrea, Cimon, Karen, Farrah, Kelly
Published 2012
Canadian Agency for Drugs and Technologies in Health
...), and other gram-negative bacteria may produce the enzymes known as extended spectrum beta-lactamases (ESBL...

2
Published 2011
Canadian Agency for Drugs and Technologies in Health
... producer and broker of health technology assessments. Health care decision-makers rely on our work to make...

3
Published 2011
Canadian Agency for Drugs and Technologies in Health
... producer and broker of health technology assessments. Health care decision-makers rely on our work to make...

4
by Banerjee, Srabani, McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
...., fentanyl), propofol, and ketamine. Ketamine is a N-methyl-D aspartate receptor antagonist that produces a...

5
by Banerjee, Srabani, McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
...., fentanyl), propofol, and ketamine. Ketamine is a N-methyl-D aspartate receptor antagonist that produces a...

6
Published 2017
Canadian Agency for Drugs and Technologies in Health
... of pain severe enough to require daily, continuous, long-term opioid treatment. Buprenorphine produces...

7
Published 2012
Canadian Agency for Drugs and Technologies in Health

8
Published 2012
Canadian Agency for Drugs and Technologies in Health

11
Published 2017
Canadian Agency for Drugs and Technologies in Health
... producer N-acetyl glutamate synthetase; or in the ornithine transporter and citrin. The estimated incidence...

12
Published 2018
Canadian Agency for Drugs and Technologies in Health

13
Published 2017
Canadian Agency for Drugs and Technologies in Health

14
Published 2018
Canadian Agency for Drugs and Technologies in Health

15
Published 2016
Canadian Agency for Drugs and Technologies in Health
... in these patients. This report is an update of two previous reports on this topic, produced by the Canadian Agency...

16
Published 2016
Canadian Agency for Drugs and Technologies in Health
... in these patients. This report is an update of two previous reports on this topic, produced by the Canadian Agency...

17
Published 2014
Canadian Agency for Drugs and Technologies in Health
...The purpose of this review is to provide an update of a Rapid Response report produced by CADTH...

18
Published 2014
Canadian Agency for Drugs and Technologies in Health
...The purpose of this review is to provide an update of a Rapid Response report produced by CADTH...

19
Published 2015
Canadian Agency for Drugs and Technologies in Health
... alone. The finding of this report can help produce clinical evidence as well as policy directions...

20
by Peprah, Kwakye, Severn, Melissa
Published 2019
CADTH
...In 2017, CADTH produced a Rapid Response report summarizing evidence on the comparative clinical...